NxStage Medical Inc recalls NxStage PureFlow-B Solution. Catalog numbers: RFP-400, RFP-401, RFP-402, RFP-403, RFP-404, RFP-406, RFP-453, RFP-454, R…
- Recall date
- April 28, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1864-2025
- FDA classification
- Class II
- Brand / firm
- NxStage Medical Inc
- Sold / distributed
- US Nationwide distribution.
Why it was recalled
Potential for the perimeter seal on the small chamber of the two-chamber bag to fail causing the electrolyte fluid to splash into the face of the user when attempting to open the peel seam to mix the two chambers prior to treatment.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
NxStage PureFlow-B Solution. Catalog numbers: RFP-400, RFP-401, RFP-402, RFP-403, RFP-404, RFP-406, RFP-453, RFP-454, RFP-456.
Get recall alerts
Free email alert whenever NxStage Medical Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: NxStage Medical Inc